HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/4/F768    most recent 00163.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Liu, Y. Articles by de Borst, M. H. Search for Related Content PubMed PubMed Citation Articles by Liu, Y. Articles by de Borst, M. H.

Neonatal dexamethasone administration causes progressive renal damage due to induction of an early inflammatory response

¹Center for Liver, Digestive, and Metabolic Diseases, Laboratory of Pediatrics; ²Department of Pathology and Laboratory Medicine; University Medical Center Groningen, University of Groningen, Groningen; ³Unit Life Sciences, Van Hall University of Applied Sciences, Leeuwarden; ⁴Department of Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, The Netherlands; and ⁵Department of Endocrinology, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China

Submitted 8 April 2007 ; accepted in final form 25 January 2008

Glucocorticoids (GCs) are widely used to prevent chronic lung disease in immature newborns. Emerging evidence indicates that GC exposure in early life may interfere with kidney function and is associated with hypertension in later life. In this study, we have investigated the effect of neonatal dexamethasone (DEX) administration on renal function in rats. Male rats were treated with DEX in the first 3 days after birth, controls received saline (SAL). Severe renal damage associated with premature death was found at 50 wks upon DEX treatment, while renal function and morphology were normal in controls. A subsequent time-course study was performed from 2 days to 32 wks. Compared with controls, neonatal DEX administration led to significant and persistent growth retardation. Progressive proteinuria and increased systolic blood pressure were found from 8 wks onwards in DEX-treated animals. Renal -SMA gene expression was elevated from wk 24 onwards and morphological fibrosis was noted at 32 wks of age following DEX treatment. Markedly increased renal gene expression of TNF- and MCP-1 in DEX -treated rats was observed at day 7, probably contributing to the permanent increase in interstitial macrophage numbers that started at 14 days. Permanently elevated renal TGF-β gene expression was induced by DEX administration from 4 wks onwards. Our data indicate that neonatal DEX administration in rats leads to renal failure in later life, presumably due to an early inflammatory trigger that elicits a persistent pro-fibrotic process that eventually results in progressive renal deterioration.

newborn; glucocorticoids; kidney failure; inflammation